Kaléo’s engagement with Brittany Mahomes’ 2 million Instagram followers has landed it in the FDA’s bad books. After seeing a Mahomes’ Instagram post that “entirely [omitted] all risk information,” the ...
The US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) has handed drugmaker Kaleo an untitled letter for failing to disclose risks associated with its epinephrine ...
Shortly after releasing an updated guidance on how the pharma industry should address health misinformation in the age of social media, the Food and Drug Administration has already pinpointed at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results